Evidence map›Paper›PMID 28817080›Full record

ArticleDiagnostics (Basel, Switzerland)2017

Feasibility Study of an Optical Caustic Plasmonic Light Scattering Sensor for Human Serum Anti-Dengue Protein E Antibody Detection.

Antonio A García, Lina S Franco, Miguel A Pirez-Gomez, José L Pech-Pacheco, Jorge F Mendez-Galvan, Carlos Machain-Williams, Lourdes Talavera-Aguilar, José H Espinosa-Carrillo, Miriam M Duarte-Villaseñor, Christian Be-Ortiz and 3 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Recent Developments in Nanotechnology for Detection and Control ofFrontiers in bioengineering and biotechnology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Antonio A GarcíaSchool of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ 85287, USA. tony.garcia@asu.edu.
Lina S FrancoSchool of Molecular Sciences, Arizona State University, Tempe, AZ 85287, USA. lsfranco@asu.edu.
Miguel A Pirez-GomezSolexvintel S.A. de C.V., Ciudad de Mexico 01219, Mexico. Miguel@solexvintel.com.mx.
José L Pech-PachecoSolexvintel S.A. de C.V., Ciudad de Mexico 01219, Mexico. joseluis@solexvintel.com.mx.
Jorge F Mendez-GalvanHospital Infantil de México Federico Gomez, Secretaria de Salud, Ciudad de Mexico 6720, Mexico. Jorge.f.mendez@gmail.com.
Carlos Machain-WilliamsLaboratorio de Arbovirología, Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autonoma de Yucatán, Mérida 9709, Mexico. carlos.machain@correo.uady.mx.
Lourdes Talavera-AguilarLaboratorio de Arbovirología, Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autonoma de Yucatán, Mérida 9709, Mexico. talaveralourdes@gmail.com.
José H Espinosa-CarrilloSolexvintel S.A. de C.V., Ciudad de Mexico 01219, Mexico. jose.hector@solexvintel.com.mx.
Miriam M Duarte-VillaseñorSolexvintel S.A. de C.V., Ciudad de Mexico 01219, Mexico. Programador3@solexvintel.com.mx.
Christian Be-OrtizHemolab Scientific S.A. de C.V., Merida 97100, Mexico. beortizchristian@gmail.com.
Luz E Espinosa-de Los MonterosSolexvintel S.A. de C.V., Ciudad de Mexico 01219, Mexico. espinosaluzelena@hotmail.com.
Ariel Castillo-PachecoHemolab Scientific S.A. de C.V., Merida 97100, Mexico. drjosearielcastillo@hotmail.com.
Julian E Garcina-RejonLaboratorio de Arbovirología, Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autonoma de Yucatán, Mérida 9709, Mexico. julian.garcia@correo.uady.mx.
Autonomous University of Yucatán · MXArizona State University · USSecretaria de Salud · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibody detection and accurate diagnosis of tropical diseases is essential to help prevent the spread of disease. However, most detection methods lack cost-effectiveness and field portability, which are essential features for achieving diagnosis in a timely manner. To address this, 3D-printed oblate spheroid sample chambers were fabricated to measure green light scattering of gold nanoparticles using an optical caustic focus to detect antibodies. Scattering signals of 20-200 nm gold nanoparticles using a green laser were compared to green light emitting diode (LED) light source signals and to Mie theory. The change in signal from 60 to 120 nm decreased in the order of Mie Theory > optical caustic scattering > 90° scattering. These results suggested that conjugating 60 nm gold nanoparticles and using an optical caustic system to detect plasmonic light scattering, would result in a sensitive test for detecting human antibodies in serum. Therefore, we studied the light scattering response of conjugated gold nanoparticles exposed to different concentrations of anti-protein E antibody, and a feasibility study of 10 human serum samples using dot blot and a handheld optical caustic-based sensor device. The overall agreement between detection methods suggests that the new sensor concept shows promise to detect gold nanoparticle aggregation in a homogeneous assay. Further testing and protocol optimization is needed to draw conclusions on the positive and negative predictive values for this new testing system.

Indexed as

Denguegold nanoparticleslight scatteringoptical causticprotein E

Identifiers

PMID28817080
PMCPMC5617947
OpenAlexW2550893416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.